Clinical efficacy of renal dosing adjustments of ceftazidime–avibactam in patients affected by carbapenem‐resistant Gram‐negative infections: A systematic review and meta‐analysis of observational studies

Ceftazidime-avibactam use for KPC-Kp infections: a retrospective observational multicenter study

(2021) Mario Tumbarello et al.   CLINICAL INFECTIOUS DISEASES

Pharmacokinetic/pharmacodynamic target attainment in critically ill renal patients on antimicrobial usage: focus on novel beta-lactams and beta lactams/beta-lactamase inhibitors

(2021) Milo Gatti et al.   Expert Review of Clinical Pharmacology

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

(2021) Matthew J Page et al.   BMJ-British Medical Journal

Continuous versus intermittent infusion of antibiotics in Gram-negative multidrug-resistant infections

(2021) Milo Gatti et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Assessment of a PK/PD Target of Continuous Infusion Beta-Lactams Useful for Preventing Microbiological Failure and/or Resistance Development in Critically Ill Patients Affected by Documented Gram-Negative Infections

(2021) Milo Gatti et al.   Antibiotics-Basel

Ceftazidime-avibactam in the treatment of infections caused by KPC-producing Klebsiella pneumoniae: factors associated with clinical efficacy in a single-center cohort

(2020) Juan José Castón et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Does dose reduction of renally cleared antibiotics in patients with impaired renal function lead to adequate drug exposure? A systematic review

(2020) Suzanne L. de Vroom et al.   CLINICAL MICROBIOLOGY AND INFECTION

Clinical characteristics and outcomes of patients with multidrug-resistant Gram-negative bacterial infections treated with ceftazidime/avibactam

(2020) Huan Kuang et al.   Journal of Global Antimicrobial Resistance

THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets

(2019) Stephen P H Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

Real-World Experience With Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections

(2019) Sarah C J Jorgensen et al.   Open Forum Infectious Diseases

Renal Dosing of Antibiotics: Are We Jumping the Gun?

(2018) Ryan L Crass et al.   CLINICAL INFECTIOUS DISEASES

Suboptimal Clinical Response Rates with Newer Antibiotics Among Patients with Moderate Renal Impairment: Review of the Literature and Potential Pharmacokinetic and Pharmacodynamic Considerations for Observed Findings

(2018) Monique R. Bidell et al.   PHARMACOTHERAPY

Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program

(2016) John E. Mazuski et al.   CLINICAL INFECTIOUS DISEASES

Antimicrobial Resistance

(2016) Hilary D. Marston et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

(2016) Jonathan AC Sterne et al.   BMJ-British Medical Journal

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

(2016) Jonathan AC Sterne et al.   BMJ-British Medical Journal